CK19 mRNA expression measured by reverse-transcription polymerase chain reaction (RT-PCR) in the peripheral blood of patients with non-small cell lung cancer treated by chemo-radiation: An independent prognostic factor

Lung Cancer

Volumn 56, Issue 1, 2007, Pages 105-114

  Chen, Ting Feng ^a,b   Jiang, Guo Liang ^a,b   Fu, Xiao Long ^a,b   Wang, Li Juan ^a,b   Qian, Hao ^a,b   Wu, Kai Liang ^a,b   Zhao, Sen ^a,b  

^a FUDAN UNIVERSITY SHANGHAI CANCER CENTER   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

Chemotherapy; Circulating tumor cells; Cytokeratin 19; Non small cell lung cancer; Peripheral blood; Radiation; Reverse transcriptase polymerase chain reaction (RT PCR)

Indexed keywords

CYTOKERATIN 19; MESSENGER RNA; MITOMYCIN C; VINDESINE;

ADULT; AGED; ARTICLE; CANCER CELL; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CORRELATION ANALYSIS; FEMALE; HUMAN; HUMAN CELL; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; CARCINOMA, NON-SMALL-CELL LUNG; CHI-SQUARE DISTRIBUTION; COMBINED MODALITY THERAPY; FEMALE; HUMANS; KERATIN-19; LUNG NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SENSITIVITY AND SPECIFICITY; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 33847656640     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2006.11.006     Document Type: Article

References (17)

1. Greenlee R.T., Hill-Harmon M., Murray T., and Thun M. Cancer Statistics, 2001. CA Cancer J Clin 51 (2001) 15-36
2. Department of Epidemiology of Shanghai Cancer Institute. Annual Report of Cancer Incidence (2000). Tumor 23 (2003) 532
3. Jiang Z.Q., Jiang G.L., Shi D.R., Zhang R.X., Fu X.L., and Qian H. Study of prognostic factors in patients with stage I non-small cell lung cancer. Zhonghua Zhong Liu Za Zhi 26 (2004) 364-368
4. Chen Z.L., Perez S., Holmes E.C., Wang H.J., Coulson W.F., Wen D.R., et al. Frequency and distribution of occult micrometastases in lymph nodes of patients with non-small-cell lung carcinoma. J Natl Cancer Inst 85 (1993) 493-498
5. Nicholson A.G., Graham A.N., Pezzella F., Agneta G., Goldstraw P., and Pastorino U. Does the use of immunohistochemistry to identify micrometastases provide useful information in the staging of node-negative non-small cell lung carcinoma?. Lung Cancer 18 (1997) 231-240
6. Osaki T., Oyama T., Gu C.D., Yamashita T., So T., Takenoyama M., et al. Prognostic impact of micrometastatic tumor cells in the lymph nodes and bone marrow of patients with completely resected stage I non-small cell lung cancer. J Clin Oncol 20 (2002) 2930-2936
7. Pantel K., Izbicki J., Passlick B., Angstwurm M., Haussinger K., Thetter O., et al. Frequency and prognostic significance of isolated tumor cells in bone marrow of patients with non-small cell lung cancer without overt metastases. Lancet 347 (1996) 649-653
8. Peck K., Sher Y.P., Shih J.Y., Roffler S.R., Wu C.W., and Yang P.C. Detection and quantitation of circulating cancer cells in the PB of lung cancer patients. Cancer Res 58 (1998) 2761-2765
9. Kurusu Y., Yamashita J., and Ogawa M. Detection of circulating tumor cells by reverse transcriptase-polymerase chain reaction in patients with resectable non-small-cell lung cancer. Surgery 126 (1999) 820-826
10. Yamashita J., Matsuo A., Kurusu Y., Saishoi T., Hayashi N., and Ogawa M. Preoperative evidence of circulating tumor cells by means of reverse transcriptase-polymerase chain reaction for carcinoembryonic antigen messenger RNA is an independent predictor of survival in non-small cell lung cancer: a prospective study. J Thorac Cardiovasc Surg 124 (2002) 299-305
11. Pfister D.G., Johnson D.H., Azzoli C.G., Sause W., Smith T.J., Baker Jr. S., et al. American Society of Clinical Oncology treatment of unresectable non-small-cell lung cancer guideline: update 2003. J Clin Oncol 22 (2004) 330-353
12. Chomczynski P., and Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162 (1987) 156-159
13. Smith B., Selby P., Southgate J., Pittman K., Bradley C., and Blair G.E. Detection of melanoma cells in peripheral blood by means of reverse transcriptase and polymerase chain reaction. Lancet 338 (1991) 1227-1229
14. Stathopoulou A., Vlachonikolis I., Mavroudis D., Perraki M., Kouroussis Ch, Apostolaki S., et al. Molecular detection of cytokeratin-19-positive cells in the peripheral blood of patients with operable breast cancer: evaluation of their prognostic significance. J Clin Oncol 20 (2002) 3404-3412
15. Lin J.C., Chen K.Y., Wang W.Y., Jan J.S., Liang W.M., and Wei Y.H. Evaluation of cytokeratin-19 mRNA as a tumor marker in the peripheral blood of nasopharyngeal carcinoma patients receiving concurrent chemoradiotherapy. Int J Cancer 97 (2002) 548-553
16. Ruud P., Fodstad O., and Hovig E. Identification of a novel cytokeratin 19 pseudogene that may interfere with reverse transcriptase-polymerase chain reaction assays used to detect micrometastatic tumor cells. Int J Cancer 80 (1999) 119-125
17. Krismann M., Todt B., Schröder J., Gareis D., Muller K.M., Seeber S., et al. Low specificity of cytokeratin 19 reverse transcriptase-polymerase chain reaction analyses for detection of hematogenous lung cancer dissemination. J Clin Oncol 13 (1995) 2769-2775